9. Downstream Health and Economic Outcomes of Pembrolizumab in the Treatment of NSCLC and Melanoma in Italy

Via Columbia 2, 00133 Rome, Italy
C.f. 97803280581

segreteria.rome@isporitaly.org

Linkedin

©Copyright 2025 | ISPOR Italy – Rome Regional ChapterÂ